First real-world data on Mavyret showing safety & effectiveness in HCV Genotype 1-6 - Hallo friendsTHE LEK NEWS, In the article you read this time with the title First real-world data on Mavyret showing safety & effectiveness in HCV Genotype 1-6, We have prepared this article for you to read and retrieve information therein. Hopefully the contents of postings Article culture, Article economy, Article health, Article healthy tips, Article news, Article politics, Article sports, We write this you can understand. Alright, good read.

Title : First real-world data on Mavyret showing safety & effectiveness in HCV Genotype 1-6
link : First real-world data on Mavyret showing safety & effectiveness in HCV Genotype 1-6

First real-world data on Mavyret showing safety & effectiveness in HCV Genotype 1-6

Shared on Twitter today by @HenryEChang - First real-world data from the Deutsches Hepatitis C-Register (DHC-R) showing favorable safety & excellent effectiveness of G/P in HCV GT1-6 patients with 97% SVR12 & no virologic failures to date.

FIRST REAL - WORLD DATA ON SAFETY AND EFFECTIVENESS OF GLECAPREVIR/PIBRENTASVIR FOR THE TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION: DATA FROM THE GERMAN HEPATITIS C - REGISTRY

Download it here.... http://jmp.sh/VthHp48

Related:
Mavyret (glecaprevir/pibrentasvir)
Liver Congress™ 2018 First real-world studies report glecaprevir/pibrentasvir to be effective and well tolerated in chronic HCV infection
April 12, 2018
The results of the first real-world studies assessing the effectiveness and safety of glecaprevir/pibrentasvir (G/P) in patients with chronic hepatitis C virus (HCV) infection have confirmed high rates of viral suppression and a favourable safety profile in patients receiving 8-16 weeks of treatment.

Real-world experience confirms Mavyret efficacy in HCV
April 12, 2018
PARIS — Two real-world studies presented at the International Liver Congress 2018 confirmed the efficacy and safety of Mavyret in Italy and…

Thus Article First real-world data on Mavyret showing safety & effectiveness in HCV Genotype 1-6

That's an article First real-world data on Mavyret showing safety & effectiveness in HCV Genotype 1-6 This time, hopefully can give benefits to all of you. well, see you in posting other articles.

You are now reading the article First real-world data on Mavyret showing safety & effectiveness in HCV Genotype 1-6 with the link address https://theleknews.blogspot.com/2018/04/first-real-world-data-on-mavyret.html

Tweet

Subscribe to receive free email updates: